Literature DB >> 26188533

Prevalence and correlates of mitral annular calcification in adults with chronic kidney disease: Results from CRIC study.

Moshrik Abd Alamir1, Vlad Radulescu2, Michael Goyfman2, Emile R Mohler3, Yan Lin Gao1, Matthew J Budoff4.   

Abstract

BACKGROUND: Risk factors for mitral annular calcification (MAC) and cardiovascular disease (CVD) demonstrate significant overlap in the general population. The aim of this paper is to determine whether there are independent relationships between MAC and demographics, traditional and novel CVD risk factors using cardiac CT in the Chronic Renal Insufficiency Cohort (CRIC) in a cross-sectional study.
METHODS: A sample of 2070 subjects underwent coronary calcium scanning during the CRIC study. Data were obtained for each participant at time of scan.
SUBJECTS: were dichotomized into the presence and absence of MAC. Differences in baseline demographic and transitional risk factor data were evaluated across groups. Covariates used in multivariable adjustment were age, gender, BMI, HDL, LDL, lipid lowering medications, smoking status, family history of heart attack, hypertension, diabetes mellitus, phosphate, PTH, albuminuria, and calcium.
RESULTS: Our study consisted of 2070 subjects, of which 331 had MAC (prevalence of 16.0%). The mean MAC score was 511.98 (SD 1368.76). Age and white race remained independently associated with presence of MAC. Decreased GFR was also a risk factor. African American and Hispanic race, as well as former smoking status were protective against MAC. In multivariable adjusted analyses, the remaining covariates were not significantly associated with MAC. Among renal covariates, elevated phosphate was significant.
CONCLUSION: In the CRIC population, presence of MAC was independently associated with age, Caucasian race, decreased GFR, and elevated phosphate. These results are suggested by mechanisms of dysregulation of inflammation, hormones, and electrolytes in subjects with renal disease.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac computed tomographic angiography; Coronary atherosclerosis; Mitral annular calcification

Mesh:

Substances:

Year:  2015        PMID: 26188533      PMCID: PMC4546905          DOI: 10.1016/j.atherosclerosis.2015.07.013

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  37 in total

Review 1.  HDL functionality.

Authors:  Handrean Soran; Salam Hama; Rahul Yadav; Paul N Durrington
Journal:  Curr Opin Lipidol       Date:  2012-08       Impact factor: 4.776

2.  Trends in coronary artery calcification in peritoneal dialysis and transplant patients.

Authors:  Tomasz Stompór; Mieczyslaw Pasowicz; Wladyslaw Sulowicz; Aldona Dembinska-Kiec; Wieslawa Tracz
Journal:  Nephrol Dial Transplant       Date:  2004-12       Impact factor: 5.992

3.  Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study.

Authors:  J Jeffrey Carr; Jennifer Clark Nelson; Nathan D Wong; Michael McNitt-Gray; Yadon Arad; David R Jacobs; Stephan Sidney; Diane E Bild; O Dale Williams; Robert C Detrano
Journal:  Radiology       Date:  2005-01       Impact factor: 11.105

4.  Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study.

Authors:  Caroline S Fox; Martin G Larson; Ramachandran S Vasan; Chao-Yu Guo; Helen Parise; Daniel Levy; Eric P Leip; Christopher J O'donnell; Ralph B D'Agostino; Emelia J Benjamin
Journal:  J Am Soc Nephrol       Date:  2005-12-28       Impact factor: 10.121

5.  Plasma osteoprotegerin levels are associated with glycaemic status, systolic blood pressure, kidney function and cardiovascular morbidity in type 1 diabetic patients.

Authors:  Lars Melholt Rasmussen; Lise Tarnow; Troels Krarup Hansen; Hans-Henrik Parving; Allan Flyvbjerg
Journal:  Eur J Endocrinol       Date:  2006-01       Impact factor: 6.664

6.  Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study.

Authors:  Matthew J Budoff; Daniel J Rader; Muredach P Reilly; Emile R Mohler; Jim Lash; Wei Yang; Leigh Rosen; Melanie Glenn; Valerie Teal; Harold I Feldman
Journal:  Am J Kidney Dis       Date:  2011-07-23       Impact factor: 8.860

Review 7.  Importance of high-density lipoprotein quality: evidence from chronic kidney disease.

Authors:  Valentina Kon; T Alp Ikizler; Sergio Fazio
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-05       Impact factor: 2.894

8.  Upregulation of matrix metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease.

Authors:  Ada W Y Chung; H H Clarice Yang; Jong Moo Kim; Mhairi K Sigrist; Elliott Chum; William A Gourlay; Adeera Levin
Journal:  Circulation       Date:  2009-08-17       Impact factor: 29.690

9.  Estrogen inhibits RANKL-stimulated osteoclastic differentiation of human monocytes through estrogen and RANKL-regulated interaction of estrogen receptor-alpha with BCAR1 and Traf6.

Authors:  Lisa J Robinson; Beatrice B Yaroslavskiy; Reed D Griswold; Eva V Zadorozny; Lida Guo; Irina L Tourkova; Harry C Blair
Journal:  Exp Cell Res       Date:  2009-01-30       Impact factor: 3.905

10.  Circulating fibroblast growth factor 23 is associated with angiographic severity and extent of coronary artery disease.

Authors:  Yunjun Xiao; Chaoqiong Peng; Wei Huang; Jinzhou Zhang; Min Xia; Yuan Zhang; Wenhua Ling
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

View more
  7 in total

Review 1.  Mitral Annular Calcification: Association with Atherosclerosis and Clinical Implications.

Authors:  Luiz Rafael P Cavalcanti; Michel Pompeu B O Sá; Álvaro M Perazzo; Antonio C Escorel Neto; Rafael A F Gomes; Alexander Weymann; Konstantin Zhigalov; Arjang Ruhparwar; Ricardo C Lima
Journal:  Curr Atheroscler Rep       Date:  2020-02-07       Impact factor: 5.113

Review 2.  Valvular heart disease in patients with chronic kidney disease.

Authors:  Julian Hoevelmann; Felix Mahfoud; Lucas Lauder; Bruno Scheller; Michael Böhm; Sebastian Ewen
Journal:  Herz       Date:  2021-01-04       Impact factor: 1.443

3.  Determinants and Outcomes Associated With Urinary Calcium Excretion in Chronic Kidney Disease.

Authors:  Jing Liu; Maria Clarissa Tio; Ashish Verma; Insa M Schmidt; Titilayo O Ilori; Felix Knauf; Finnian R Mc Causland; Sushrut S Waikar
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 6.134

Review 4.  [Valvular heart disease in patients with chronic kidney disease].

Authors:  S Ewen; F Mahfoud; L Lauder; B Scheller; M Böhm
Journal:  Internist (Berl)       Date:  2020-04       Impact factor: 0.743

5.  Association of tubular solute clearances with the glomerular filtration rate and complications of chronic kidney disease: the Chronic Renal Insufficiency Cohort study.

Authors:  Yan Chen; Leila R Zelnick; Ke Wang; Ronit Katz; Andrew N Hoofnagle; Jessica O Becker; Chi-Yuan Hsu; Alan S Go; Harold I Feldman; Rupal C Mehta; James P Lash; Sushrut S Waikar; L Hamm; Jing Chen; Tariq Shafi; Bryan R Kestenbaum
Journal:  Nephrol Dial Transplant       Date:  2020-11-17       Impact factor: 5.992

6.  Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Yan Chen; Leila R Zelnick; Matthew P Huber; Ke Wang; Nisha Bansal; Andrew N Hoofnagle; Rajan K Paranji; Susan R Heckbert; Noel S Weiss; Alan S Go; Chi-Yuan Hsu; Harold I Feldman; Sushrut S Waikar; Rupal C Mehta; Anand Srivastava; Stephen L Seliger; James P Lash; Anna C Porter; Dominic S Raj; Bryan R Kestenbaum
Journal:  Am J Kidney Dis       Date:  2021-01-07       Impact factor: 11.072

7.  Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.

Authors:  Joachim Jankowski; Jürgen Floege; Danilo Fliser; Michael Böhm; Nikolaus Marx
Journal:  Circulation       Date:  2021-03-15       Impact factor: 29.690

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.